vs
Side-by-side financial comparison of Barnes & Noble Education, Inc. (BNED) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $598.2M, roughly 1.0× Barnes & Noble Education, Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs 4.2%, a 30.3% gap on every dollar of revenue. On growth, Barnes & Noble Education, Inc. posted the faster year-over-year revenue change (6.9% vs 4.8%). Over the past eight quarters, Barnes & Noble Education, Inc.'s revenue compounded faster (20.0% CAGR vs 4.6%).
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
BNED vs RPRX — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $598.2M | $622.0M |
| Net Profit | $25.0M | $214.2M |
| Gross Margin | 21.7% | — |
| Operating Margin | 6.8% | 62.4% |
| Net Margin | 4.2% | 34.4% |
| Revenue YoY | 6.9% | 4.8% |
| Net Profit YoY | -49.7% | 2.9% |
| EPS (diluted) | $0.72 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $598.2M | $622.0M | ||
| Q3 25 | $274.2M | $609.3M | ||
| Q2 25 | $233.0M | $578.7M | ||
| Q1 25 | $419.7M | $568.2M | ||
| Q4 24 | $559.7M | $593.6M | ||
| Q3 24 | $250.9M | $564.7M | ||
| Q2 24 | $192.7M | $537.3M | ||
| Q1 24 | $415.4M | $568.0M |
| Q4 25 | $25.0M | $214.2M | ||
| Q3 25 | $-18.3M | $288.2M | ||
| Q2 25 | $-23.0M | $30.2M | ||
| Q1 25 | $17.9M | $238.3M | ||
| Q4 24 | $43.2M | $208.2M | ||
| Q3 24 | $-103.9M | $544.0M | ||
| Q2 24 | $-41.9M | $102.0M | ||
| Q1 24 | $-9.3M | $4.8M |
| Q4 25 | 21.7% | — | ||
| Q3 25 | 20.2% | — | ||
| Q2 25 | 30.3% | — | ||
| Q1 25 | 22.3% | — | ||
| Q4 24 | 23.0% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 28.7% | — | ||
| Q1 24 | 24.2% | — |
| Q4 25 | 6.8% | 62.4% | ||
| Q3 25 | -8.4% | 70.1% | ||
| Q2 25 | -4.9% | 36.3% | ||
| Q1 25 | 4.5% | 94.0% | ||
| Q4 24 | 8.4% | 60.9% | ||
| Q3 24 | -15.4% | — | ||
| Q2 24 | -16.3% | 50.2% | ||
| Q1 24 | 0.4% | -13.0% |
| Q4 25 | 4.2% | 34.4% | ||
| Q3 25 | -6.7% | 47.3% | ||
| Q2 25 | -9.9% | 5.2% | ||
| Q1 25 | 4.3% | 41.9% | ||
| Q4 24 | 7.7% | 35.1% | ||
| Q3 24 | -41.4% | 96.3% | ||
| Q2 24 | -21.7% | 19.0% | ||
| Q1 24 | -2.2% | 0.8% |
| Q4 25 | $0.72 | $0.49 | ||
| Q3 25 | $-0.54 | $0.67 | ||
| Q2 25 | $2.97 | $0.07 | ||
| Q1 25 | $0.59 | $0.55 | ||
| Q4 24 | $1.63 | $0.46 | ||
| Q3 24 | $-7.69 | $1.21 | ||
| Q2 24 | $-15.68 | $0.23 | ||
| Q1 24 | $-3.49 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.7M | $618.7M |
| Total DebtLower is stronger | $122.5M | $9.0B |
| Stockholders' EquityBook value | $283.2M | $9.7B |
| Total Assets | $1.1B | $19.6B |
| Debt / EquityLower = less leverage | 0.43× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.7M | $618.7M | ||
| Q3 25 | $7.3M | $938.9M | ||
| Q2 25 | $9.1M | $631.9M | ||
| Q1 25 | $9.2M | $1.1B | ||
| Q4 24 | $11.6M | $929.0M | ||
| Q3 24 | $8.2M | $950.1M | ||
| Q2 24 | $10.5M | $1.8B | ||
| Q1 24 | $8.1M | $843.0M |
| Q4 25 | $122.5M | $9.0B | ||
| Q3 25 | $170.0M | $8.9B | ||
| Q2 25 | $103.1M | $8.0B | ||
| Q1 25 | $141.2M | $7.6B | ||
| Q4 24 | $177.6M | $7.6B | ||
| Q3 24 | $221.9M | $7.6B | ||
| Q2 24 | $196.3M | $7.6B | ||
| Q1 24 | $30.2M | $6.1B |
| Q4 25 | $283.2M | $9.7B | ||
| Q3 25 | $256.5M | $9.6B | ||
| Q2 25 | $272.2M | $9.5B | ||
| Q1 25 | $292.9M | $9.8B | ||
| Q4 24 | $211.4M | $10.3B | ||
| Q3 24 | $149.8M | $10.3B | ||
| Q2 24 | $80.4M | $9.8B | ||
| Q1 24 | $121.5M | $9.9B |
| Q4 25 | $1.1B | $19.6B | ||
| Q3 25 | $950.8M | $19.3B | ||
| Q2 25 | $790.3M | $18.3B | ||
| Q1 25 | $1.1B | $17.6B | ||
| Q4 24 | $1.0B | $18.2B | ||
| Q3 24 | $973.2M | $18.0B | ||
| Q2 24 | $909.9M | $17.7B | ||
| Q1 24 | $1.2B | $16.1B |
| Q4 25 | 0.43× | 0.92× | ||
| Q3 25 | 0.66× | 0.93× | ||
| Q2 25 | 0.38× | 0.84× | ||
| Q1 25 | 0.48× | 0.78× | ||
| Q4 24 | 0.84× | 0.74× | ||
| Q3 24 | 1.48× | 0.74× | ||
| Q2 24 | 2.44× | 0.78× | ||
| Q1 24 | 0.25× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $66.2M | $827.1M |
| Free Cash FlowOCF − Capex | $61.9M | — |
| FCF MarginFCF / Revenue | 10.4% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | 2.65× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $-4.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.2M | $827.1M | ||
| Q3 25 | $-67.6M | $702.6M | ||
| Q2 25 | $52.6M | $364.0M | ||
| Q1 25 | $-41.9M | $596.1M | ||
| Q4 24 | $47.4M | $742.5M | ||
| Q3 24 | $-143.5M | $703.6M | ||
| Q2 24 | $81.7M | $658.2M | ||
| Q1 24 | $-35.8M | $664.6M |
| Q4 25 | $61.9M | — | ||
| Q3 25 | $-71.3M | — | ||
| Q2 25 | $49.5M | — | ||
| Q1 25 | $-44.7M | — | ||
| Q4 24 | $44.4M | — | ||
| Q3 24 | $-147.5M | — | ||
| Q2 24 | $79.1M | — | ||
| Q1 24 | $-39.0M | — |
| Q4 25 | 10.4% | — | ||
| Q3 25 | -26.0% | — | ||
| Q2 25 | 21.3% | — | ||
| Q1 25 | -10.7% | — | ||
| Q4 24 | 7.9% | — | ||
| Q3 24 | -58.8% | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | -9.4% | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 0.8% | — |
| Q4 25 | 2.65× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | -2.34× | 2.50× | ||
| Q4 24 | 1.10× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BNED
| Course Materials Product | $459.3M | 77% |
| General Merchandise Product | $112.9M | 19% |
| Serviceand Other | $26.1M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
